论文部分内容阅读
布局全产业链,打入高端市场随着国家食品药品监督管理总局(CFDA)正式成为国际人用药品注册技术协调会(ICH)成员,我国药品审批制度法规和理念不断完善,药品上市进程不断加强,中外资源整合的趋势越来越明显。诸多利好政策吸引着国外企业进驻中国,也鼓励着越来越多的本土药企走出国门。经过近年来的国际化探索,具备制剂国际化能力的企业逐渐增多,出海路径日趋多元化,一批提前布局国际市场的企业已经逐渐进入“早期收获期”。
Layout of the entire industrial chain, into the high-end market With the State Food and Drug Administration (CFDA) officially became a member of the International Association for the Registration of Human Drugs (ICH), China’s drug approval system regulations and concepts continue to improve, drug listing process continues to strengthen , The trend of integration of Chinese and foreign resources has become more and more obvious. Many favorable policies have attracted foreign companies to enter China, and encouraged more and more local drug companies to go abroad. After the international exploration in recent years, the number of companies that have the capability of internationalization of preparations has been gradually increasing. The diversified routes to the sea have become increasingly diversified. A number of enterprises that laid out the international markets ahead of time have gradually entered the early harvest period.